In the West of Scotland Coronary Prevention (WOSCOP) study, Wallace et al 1 show that plasma leptin levels predict coronary heart disease (CHD), and they interpret this finding on the basis of the known relationships between leptin and several facets of the metabolic syndrome, including high body mass index (BMI), insulin resistance, arterial hypertension, and of the relationship between leptin and C-reactive protein, a marker of inflammation and a predictor of CHD events. 1 Other interpretations are possible. We analyzed BMI, serum leptin levels, and the QT interval (QTc) in 45 morbidly obese subjects, and we found that loss of weight obtained through BMI and leptin (rϭ0.63, PϽ0.001; rϭ0.72, PϽ0.001, respectively), and between leptin and QTc (rϭ0.57, PϽ0.001; rϭ0.52, PϽ0.001, respectively).
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We thank Pontiroli and colleagues for their interesting comments in relation to our paper 1 on leptin as a novel risk factor for coronary heart disease (CHD). We accept that mechanisms other than those proposed in our article, including increased heart rate and long QTc, may link leptin to CHD. Fortunately, such parameters were measured at baseline in the West of Scotland Coronary Prevention Study (WOSCOPS) and we have therefore examined the relationship between leptin and the above parameters. In the 783 control subjects with leptin measurements, log leptin did not correlate with heart rate (rϭ0.03, Pϭ0.39) but did so positively with QTc (rϭ0.10, Pϭ0.005). However, body mass index (BMI) also correlated with QTc (rϭ0.15, PϽ0.001) and the association of leptin with QTc was lost with adjustment for BMI (rϭ0.018, Pϭ0.62). This observation contrasts with findings for established risk factors such as C-reactive protein and triglyceride that do correlate with leptin independently of BMI. These data suggest that total adiposity rather than fat mass per se is linked to increased QTc.
